The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases

BACKGROUND: Metastatic breast cancer (MBC) prognosis is variable, depending on several clinical and biological factors. A better prediction of a patient’s outcome could allow for a more accurate choice of treatments. The role of serum biomarkers in predicting outcome remains unclear in this setting....

Descripción completa

Detalles Bibliográficos
Autores principales: Darlix, Amélie, Hirtz, Christophe, Thezenas, Simon, Maceski, Aleksandra, Gabelle, Audrey, Lopez-Crapez, Evelyne, De Forges, Hélène, Firmin, Nelly, Guiu, Séverine, Jacot, William, Lehmann, Sylvain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354387/
https://www.ncbi.nlm.nih.gov/pubmed/30700265
http://dx.doi.org/10.1186/s12885-019-5287-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354387/
https://www.ncbi.nlm.nih.gov/pubmed/30700265
http://dx.doi.org/10.1186/s12885-019-5287-z

Ejemplares similares